Market Tracker

03/29 9:04am ET

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

47.40
Delayed Data
As of Mar 28
 -0.15 / -0.32%
Today’s Change
29.95
Today|||52-Week Range
65.64
+46.75%
Year-to-Date
4 Biotech Stocks to Watch
Mar 22 / GuruFocus News - Paid Partner Content
Why Pacira Pharmaceuticals Stock Is Already Up 56% This Year
Mar 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.55
Today’s open47.50
Day’s range46.25 - 48.10
Volume674,525
Average volume (3 months)1,097,211
Market cap$1.8B
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-2,650.00%
Earnings growth (this year)-53.36%
Earnings growth (next 5 years)+120.00%
Revenue growth (last year)+10.99%
P/E ratioNM
Price/Sales4.35
Price/Book8.11

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.80+1.58%
GBTGlobal Blood Therape...-0.70-1.77%
TBPHTheravance Biopharma...+0.63+1.78%
SRPTSarepta Therapeutics...-0.76-2.49%
Data as of 03/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$276.4M
Annual profit (last year)-$37.9M
Net profit margin-13.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts